Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder

Recruiting

Phase 0 Results N/A

Trial Description

This study mainly evaluated the feasibility and safety of LAmbre Left Atrial Appendage Occluder which is to prevent ischemic stroke caused by atrial fibrillation(AF).

Detailed Description

Atrial fibrillation (AF) is a common arrhythmia, its incidence increases with age. Thrombosis shed off caused by AF is one of the major causes of stroke. Most patients with AF suffer ischemic stroke that the thrombosis was from the left atrial appendage(LAA). The majority of patients with atrial fibrillation, the blood clots come from the left atrial appendage, so close the left atrial appendage can reduce cycle thromboembolism of the patients with AF. Now patients have cardiac surgery and risk at left atrium related thromboembolism, the surgery has been conventional perform the left atrial appendage closed surgery.
However, surgical left atrial appendage ligation is difficult to be completely closed to the left atrial appendage,internal medicine intervention methods of surgical closure the left atrial appendage is relatively simple, minimally invasive, high success rate and is expected to be widely used.
Several versions of LAA occlusion devices have been developed.LAA occluder of Lifetech consists of a umbrella, cover and conveyor; The umbrella composed of multiple umbrella and covered the ePTFE membrane.This study mainly evaluated the feasibility and safety of LAmbre Left Atrial Appendage Occluder! Through the femoral vein puncture; insert inter atrial septum puncture device; puncture a small hole in the atrial septal, delivery sheath is inserted in the femoral vein puncture site and across the atrial septal reach the left atrial appendage, establishment of the channel. Through the built-channel sent the LAA occluder to the left atrial appendage by the delivery cable; The LAA occlude will be fixed in the left atrial appendage, close the entrance of the left atrial appendage meanwhile and block blood flow; then eliminate the risk of blood clots due to atrial fibrillation, prevention stroke.

Conditions

Interventions

  • LAmber Left Atrial Appendage(LAA) Occluder Device
    Intervention Desc: Implanting the LAmber Left Atrial Appendage Occluder to close the left atrial appendage
    ARM 1: Kind: Experimental
    Label: Left Atrial Appendage Occluder
    Description: Adotped non-comparative arm on Left Atrial Appendage Occluder.
  • LAmbre Left Atrial Appendage(LAA) Occluder Device
    Intervention Desc: Implanting the LAmbre Left Atrial Appendage Occluder to close the left atrial appendage
    ARM 1: Kind: Experimental
    Label: Left Atrial Appendage Occluder
    Description: Adopted non-comparative arm on Left Atrial Appendage Occluder.

Trial Design

  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary The feasibility end-point 30 days Yes
Secondary The composite safety and efficacy end-point 12 months Yes

Sponsors